Scientists probe dangerous blood pressure spike from common anemia drug
NCT ID NCT03810911
Summary
This study aimed to understand why a drug called erythropoietin (EPO), used to treat anemia, often raises blood pressure in people with chronic kidney disease. Researchers compared blood pressure changes and blood vessel function in a small group of patients who received EPO immediately versus those who waited. The goal was to learn the mechanism behind this side effect to help design safer future treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Richard L. Roudebush VA Medical Center, Indianapolis, IN
Indianapolis, Indiana, 46202-2884, United States
Conditions
Explore the condition pages connected to this study.